Current Drug Metabolism
Volume 20, 14 Issues, 2019
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
ISSN: 1875-5453 (Online)
ISSN: 1389-2002 (Print)
This journal supports open access
Ranking and Category
-
200th of 298 in
Biochemistry & Molecular Biology
-
158th of 267 in
Pharmacology & Pharmacy
Contents
Current Drug Metabolism, Volume 18 - Number 8
Biography Open Access
Editorial Open Access
Editorial: Emerging Biomarkers in Genitourinary Tumors
, 18(8): 690 - 691Rodolfo Montironi, Antonio Lopez-Beltran and Liang Cheng
DOI: 10.2174/138920021808171016103101
Review Article
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
, 18(8): 692 - 699Chiara Ciccarese, Rodolfo Montironi, Michelangelo Fiorentino, Guido Martignoni, Matteo Brunelli, Roberto Iacovelli, Antonio Lopez-Beltran, Liang Cheng, Marina Scarpelli, Holger Moch, Giampaolo Tortora and Francesco Massari*
DOI: 10.2174/1389200218666170518163549
Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Review Article
Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
, 18(8): 700 - 711Steven A. Mann, Antonio Lopez-Beltran, Francesco Massari, Roberto Pili, Michelangelo Fiorentino, Michael O. Koch, Hristos Z. Kaimakliotis, Lisha Wang, Marina Scarpelli, Chiara Ciccarese, Holger Moch, Rodolfo Montironi and Liang Cheng*
DOI: 10.2174/1389200218666170518162500
Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Review Article
Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice
, 18(8): 712 - 722Ana Blanca, Liang Cheng, Rodolfo Montironi, Holger Moch, Francesco Massari, Michelangelo Fiorentino, Maria Rosaria Raspollini, Marina Scarpelli and Antonio Lopez-Beltran*
DOI: 10.2174/1389200218666170518164507
Mirna Expression in Bladder Cancer and Their Potential Role in Clinical Practice
Review Article
Urinary Biomarkers for Prostate Cancer
, 18(8): 723 - 726Francesca Giunchi, Chiara Ciccarese, Rodolfo Montironi, Marina Scarpelli, Antonio Lopez-Beltran, Liang Cheng, Holger Moch, Francesco Massari and Michelangelo Fiorentino*
DOI: 10.2174/1389200218666170518161140
Urinary Biomarkers for Prostate Cancer
Review Article
A Review on Pharmacokinetics of Levetiracetam in Neonates
, 18(8): 727 - 734Amit Agrawal* and Anita Banergee
DOI: 10.2174/1389200218666170607100054
A Review on Pharmacokinetics of Levetiracetam in Neonates
Review Article
Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
, 18(8): 735 - 756Roberto Mandrioli* and Laura Mercolini
DOI: 10.2174/1389200218666170406115350
Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
Review Article
Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes
, 18(8): 757 - 768T. Thanga Mariappan*, Hong Shen and Punit Marathe
DOI: 10.2174/1389200218666170724110818
Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes
Review Article
Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy
, 18(8): 769 - 781Fengyan Xu , Edward P. Acosta, Liyu Liang, Yingchun He, Juan Yang, Corenna Kerstner-Wood, Qingshang Zheng, Jihan Huang* and Kun Wang*
DOI: 10.2174/1389200218666170724112412
Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy
  |
Editor-in-Chief
Michael Sinz
Bristol Myers Squibb
Princeton, NJ
USA
Biography
View Full Editorial Board
Bristol Myers Squibb
Princeton, NJ
USA
Biography
Biography of Michael Sinz
Michael W. Sinz, Ph.D. is Director of Metabolism and Pharmacokinetics at Bristol Myers Squibb where he manages ADmezME lead optimization in drug discovery. Dr. Sinz previously held the position of Section Director-Pharmacokinetics and Drug Metabolism for Parke-Davis/Pfizer. He received B.S. degrees in Chemistry (ACS) and Biology from the University of Wisconsin-Eau Claire and a Ph.D. in Pharmacognosy/Medicinal Chemistry from the University of Minnesota (2001). He is editor in chief of Current Drug Metabolism and associate editor of Drug Metabolism Letters. Dr. Sinz’s resume includes an extensive number of peer reviewed publications, book chapters, and external presentations both locally and internationally.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Metabolism was launched in 2000. Dr. Michael Sinz serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net